Domestic Relations Law Family Law Probate Criminal Law Civil Litigation Negligence Law Litigation Elder Law & Advocacy Government Relations & Advisory Criminal Justice Elder and Special Needs Law Elder and Social Security Immigration
ISLN:
909625267
Admitted:
1993
University:
James Madison College of Michigan State University, B.A., 1985
Law School:
Thomas M. Cooley Law School, J.D., 1989
Name / Title
Company / Classification
Phones & Addresses
Linda S Powers President
SPORT HORSES UNLIMITED INC
10530 E Escalante Rd, Tucson, AZ 85730
Linda C. Powers Principal
Associated Orthodontist Hospital & Health Care · Dentist's Office
4034 E Southport Rd, Indianapolis, IN 46237 3177801958
Linda S Powers Manager
MICROBIOSYSTEMS OF ARIZONA, LLC (FN) Microbial Detection and Identification Instrumentation Development
1665 E 18 St STE 204, Tucson, AZ 85719 2574 N 200 E, Logan, UT 84341 1780 N Res Park Way, Logan, UT 84341 PO Box 6128, Logan, UT 84341 4359940206
Linda Powers
HOMES REFRESHED, LTD
Linda Powers
WALTO J. BOGGS AND ELEANOR W. BOGGS, LLC
Linda S Powers
SONORAN ANALYTICAL INSTRUMENTS AND DIAGNOSTICS, LLC
Dr. Powers graduated from the University of Wisconsin Medical School in 1981. She works in Cambridge, MA and specializes in Internal Medicine. Dr. Powers is affiliated with Mount Auburn Hospital.
South Hill Family Medicine 516 W Atlantic St, South Hill, VA 23970 4344477177 (phone), 4344473962 (fax)
Education:
Medical School University of Texas Medical Branch at Galveston Graduated: 1985
Languages:
English
Description:
Dr. Powers graduated from the University of Texas Medical Branch at Galveston in 1985. She works in South Hill, VA and specializes in Endocrinology, Diabetes & Metabolism and Diabetes. Dr. Powers is affiliated with VCU Community Memorial Hospital.
Us Patents
Neural-Network Based Electrocardiography Monitor And Associated Methods
- TUCSON AZ, US AO LI - TUCSON AZ, US STUART QUAN - TUCSON AZ, US LINDA POWERS - TUCSON AZ, US
International Classification:
A61B 5/00 G06N 3/04 G06N 3/063 A61B 5/346
Abstract:
Systems and methods detect cortical arousal events from a single time-varying ECG signal that is obtained via single-lead ECG. A pre-trained deep neural network transforms the ECG signal into a sequence of cortical-arousal probabilities. The deep neural network includes an inception module, a residual neural network, and a long short-term memory neural network to identify structure in the ECG signal that distinguishes periods of cortical arousal from periods without cortical arousal.
Linda S. Powers - Tucson AZ, US Kevin M. Okarski - Tucson AZ, US
International Classification:
G01N 33/53 B01L 3/00
Abstract:
Disclosed is a cartridge-based detection system to prepare an injected sample to be investigated for determination of a microbial pathogen or another analyte of interest using a detector features a field-safe cartridge. The system features a plurality of reagent chambers located within the cartridge. The system features a rotating cylindrical dial that facilitates a sequential introduction of various fluids contained in each reagent chamber into the dial whereby the fluid washes internally for contact therein. A dial channel is located through the dial. A dual window region of interrogation is centrally located in the dial. The dial is pivoted into position to fluidly connect each mated anterior and posterior reagent chamber via the dial channel. Methods of used are also disclosed.
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma USA - English - USA
"We are very excited to reach this important milestone as the culmination of more than 20 years of research and clinical development," commented Linda Powers, Company CEO. "We are extremely grateful to all of the parties who have made this possible, including the patients, the investigators and the
Date: Dec 21, 2023
Category: Business
Source: Google
U.K. picks a controversial brain cancer vaccine as its 1st new 'innovative medicine'
DCVax-L, though, has attracted warring bands of admirers and critics.Northwest BIO CEO Linda Powers has fed the controversy with claims that the drug is a blockbuster in the making. And she toldReuters' Ransdell Pierson in a recent interview that the drug is worth more than the $65,000 to $70,000 a
Date: Sep 16, 2014
Category: Health
Source: Google
Northwest Bio touts a chance to start selling its controversial brain cancer vaccine
The company's stock ($NWBO) has surged more than 80% in the past 6 months as investors both panned and praised the cancer vaccine. Northwest BIO CEO Linda Powers has fed the speculation with claims that the drug is a blockbuster in the making. And she tells Reuters' Ransdell Pierson in an interview